Jamestown Canyon Virus Seroprevalence in Endemic Regions and Implications for Diagnostic Testing
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Rebekah A Sutter und 21 weiteren Autor:innen. Beteiligte Einrichtung: Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, Encephalitis, California, Encephalitis Virus, California, Endemic Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, CDC, U.S. Department of Energy.
Abstract (Originalsprache)
Background
Jamestown Canyon virus, a mosquito-borne virus, can cause asymptomatic infection, febrile illness, or neuroinvasive disease in humans. Previous studies have found Jamestown Canyon virus–specific antibodies in a 4%–54% of people in various U.S. regions. To understand baseline seroprevalence in regions with the highest number of reported disease cases, we performed a serosurvey among blood donors.
Methods
We randomly selected blood donation specimens collected during December 2019–April 2020 from residents of counties reporting ≥2 disease cases in 2019 or 1 case in 2019 and ≥1 case during 2010–2018. Specimens were screened for Jamestown Canyon virus–specific neutralizing antibodies and, if positive, tested for immunoglobulin M (IgM) antibodies. We estimated county population seroprevalence by calibrating sample weights to population census data.
Results
Fourteen counties in 3 states, Massachusetts, Minnesota, and Wisconsin, met the inclusion criteria. Within each state, average county seroprevalence ranged from 16.8% (95% confidence interval [CI], 9.3–27.0) to 18.8% (95% CI, 14.0–24.4) for Jamestown Canyon virus–neutralizing antibodies and from 7.6% (95% CI, 4.2–12.5) to 13.5% (95% CI, 9.6–18.3) for both neutralizing and IgM antibodies.
Conclusions
Estimated Jamestown Canyon virus seroprevalence, including for IgM antibodies, is elevated in endemic areas, complicating the interpretation of serologic testing in diagnosing acute disease in symptomatic individuals. Diagnosing Jamestown Canyon virus disease requires a high degree of clinical suspicion, ruling out other possible causes of illness, and if possible, collecting acute and convalescent samples. New assays to detect acute infection could improve diagnosis and public health surveillance for Jamestown Canyon virus disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
- American Red Cross Scientific Affairs, Gaithersburg, Maryland, USA.
- Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA.
- Division of Public Health, Wisconsin Department of Health Services, Madison, Wisconsin, USA.
- Infectious Disease Epidemiology, Prevention, and Control Division, Minnesota Department of Health, St. Paul, Minnesota, USA.
ORCID-Profile: Rebekah A Sutter, Amanda E Calvert, Brad J Biggerstaff, Eric C Mossel, Stacey W Martin, Jennifer Lehman, Paula Saa, Rebecca Osborn, Xia Lee, Elizabeth K Schiffman, Carolyn V Gould
Förderung
- Intramural CDC HHS
- CDC
- U.S. Department of Energy
- Oak Ridge Institute for Science and Education
Zitieren
APA
Sutter, R. A., Calvert, A. E., Grimm, K., Biggerstaff, B. J., Thrasher, E., Mossel, E. C., Martin, S. W., Lehman, J., Saa, P., Townsend, R., Krysztof, D., Brown, C. M., Osborne, M., Hopkins, B., Osborn, R., Lee, X., Schiffman, E. K., Brault, A. C., Basavaraju, S. V., …, & Gould, C. V. (2025). Jamestown Canyon Virus Seroprevalence in Endemic Regions and Implications for Diagnostic Testing. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf131
Vancouver
Sutter RA, Calvert AE, Grimm K, Biggerstaff BJ, Thrasher E, Mossel EC, et al. Jamestown Canyon Virus Seroprevalence in Endemic Regions and Implications for Diagnostic Testing. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf131
BibTeX
@article{Sutter2025,
author = {Sutter, Rebekah A and Calvert, Amanda E and Grimm, Kacie and Biggerstaff, Brad J and Thrasher, Elisa and Mossel, Eric C and Martin, Stacey W and Lehman, Jennifer and Saa, Paula and Townsend, Rebecca and Krysztof, David and Brown, Catherine M and Osborne, Matthew and Hopkins, Brandi and Osborn, Rebecca and Lee, Xia and Schiffman, Elizabeth K and Brault, Aaron C and Basavaraju, Sridhar V and Stramer, Susan L and Staples, J Erin and Gould, Carolyn V},
title = {Jamestown Canyon Virus Seroprevalence in Endemic Regions and Implications for Diagnostic Testing},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf131}
}
EUVIMED